Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome

There are no proven safe and effective therapies for children who develop life-threatening complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma (CP) has demonstrated potential benefit in adults with SARS-CoV-2, but has theoretical risks.We present the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Diorio, Caroline, Anderson, Elizabeth M., McNerney, Kevin O., Goodwin, Eileen C., Chase, Julie C., Bolton, Marcus J., Arevalo, Claudia P., Weirick, Madison E., Gouma, Sigrid, Vella, Laura A., Henrickson, Sarah E., Chiotos, Kathleen, Fitzgerald, Julie C., Kilbaugh, Todd J., Odom John, Audrey R., Blatz, Allison M., Lambert, Michele P., Sullivan, Kathleen E., Tartaglione, Margaret R., Zambrano, Danielle, Martin, Meghan, Lee, Jessica H., Young, Pampee, Friedman, David, Sesok-Pizzini, Deborah A., Hensley, Scott E., Behrens, Edward M., Bassiri, Hamid, Teachey, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734626/
https://www.ncbi.nlm.nih.gov/pubmed/32885904
http://dx.doi.org/10.1002/pbc.28693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734626/
https://www.ncbi.nlm.nih.gov/pubmed/32885904
http://dx.doi.org/10.1002/pbc.28693

Ejemplares similares